BioNote377740
BioNote (377740) Preliminary Earnings, Nov 12, 2026
Filing date ·
BioNote reported preliminary Q3 2026 results (consolidated): Revenue of KRW 32.1 billion (+8.7% year over year), operating profit of KRW 8 billion (+65.6% year…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.